| Literature DB >> 27563867 |
Wen Ren1, Qian Zhao2, Chuan Zheng3, Qiong Zhao4, Li Guo5, Wei Huang6.
Abstract
Drug-like spirocyclic scaffolds have been prepared by fusing fully functionalized pyrrolidine with oxindoles in an approach based on 1,3-dipolar cycloaddition. Reaction between aziridine and 3-ylideneoxindole generated diverse spirooxindole-pyrrolidines in good yield (up to 95%) with high diastereoselectivity (up to >20:1). The reaction also proceeded smoothly with several other synthetically useful activated trisubstituted olefins. The mild reaction conditions, short reaction times, and high tolerance for various substitutions make this approach attractive for constructing pharmacologically interesting spiro-architectures.Entities:
Keywords: 1,3-dipolar cycloaddition; aziridine; single-step reaction; spirooxindole-pyrrolidine
Mesh:
Substances:
Year: 2016 PMID: 27563867 PMCID: PMC6274301 DOI: 10.3390/molecules21091113
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Examples of the spirooxindole-pyrrolidine framework in biologically active molecules.
Scheme 11,3-Dipolar cycloaddition-based synthesis of spirooxindole-pyrrolidines.
Scheme 2Synthetic strategy.
Optimization of the reaction conditions a.
| Entry | Solvent | t (h) b | T (°C) c | Additive | Yield (%) d | |
|---|---|---|---|---|---|---|
| 1 | MeCN | 4 | 90 | - | 40 (30) | 3:1 |
| 2 | EtOH | 4 | 90 | - | 33 (25) | 3:1 |
| 3 | toluene | 4 | 90 | - | 45 (36) | 4:1 |
| 4 | 1,4-dioxane | 4 | 90 | - | 35 (26) | 3:1 |
| 5 | DCM | 4 | 90 | - | 37 (28) | 3:1 |
| 6 | toluene | 12 | 70 | - | <10 | - |
| 7 | toluene | 0.5 | 110 | - | 55 (37) | 2:1 |
| 8 | toluene | 0.5 | 110 | CH3COOH | 67 (51) | 3:1 |
| 9 | toluene | 0.5 | 110 | HCOOH | 34 (27) | 4:1 |
| 10 | toluene | 0.5 | 110 | ClCH2COOH | 47 (38) | 4:1 |
| 11 | toluene | 0.5 | 110 | CF3COOH | n.r. | - |
| 12 | toluene | 0.5 | 110 | DBU | 52 (42) | 4:1 |
| 13 | toluene | 0.5 | 110 | DABCO | 65 (49) | 3:1 |
| 14 | toluene | 0.5 | 110 | K2CO3 | 57 (43) | 3:1 |
| 15 | toluene | 0.5 | 110 | TEA | 78 (65) | 5:1 |
| 16 | toluene | 4 | 90 | TEA | 72 (58) | 4:1 |
| 17 f | toluene | 0.5 | 110 | TEA | 66 (53) | 4:1 |
a Reaction conditions: additive (0.5 mmol) was added to a solution of 3-ylideneoxindole 1a (1.1 mmol) and aziridine 2a (1.0 mmol) in solvent (2 mL) at the indicated temperature. b Time for one-step reaction. c Temperature of one-step reaction. d Total yield of the mixed two isomers; the yield of the isolated major isomer 3a was shown in parentheses. e Based on crude 1H-NMR analysis of the mixed two isomers. f 2a′ was used. MeCN = acetonitrile; DCM = dichloromethane; TEA = triethylamine.
Evaluation of substrate scope under optimized reaction conditions a.
| Entry | R1 | R2 | R3 | R4 | Product | Yield (%) b | |
|---|---|---|---|---|---|---|---|
| 1 | H | COOEt | H | Ph | 78 (65) | 5:1 | |
| 2 | 4-Br | COOEt | H | Ph | 82 (59) | 2.5:1 | |
| 3 | 5-F | COOEt | H | Ph | 83 (67) | 4:1 | |
| 4 | 5-CH3 | COOEt | H | Ph | 81 (69) | 6:1 | |
| 5 | H | COO | H | Ph | 81 (65) | 4:1 | |
| 6 | H | COOPh | H | Ph | 87 (70) | 4:1 | |
| 7 | H | (CN)2 | H | Ph | 86 (69) | 4:1 | |
| 8 | H | Ph | H | Ph | 63 (61) | >20:1 | |
| 9 | H | 4-Br-C6H4 | H | Ph | 68 (58) | 6:1 | |
| 10 | H | 2-F-C6H4 | H | Ph | 66 (63) | >20:1 | |
| 11 | H | 4-NO2-C6H4 | H | Ph | 62 (52) | 5:1 | |
| 12 | H | 4-Me-C6H4 | H | Ph | 58 (56) | >20:1 | |
| 13 | H | 3,4-(MeO)2-C6H4 | H | Ph | 57 (46) | 4:1 | |
| 14 | H | 2-naphthyl | H | Ph | 55 (53) | >20:1 | |
| 15 | H | 2-furyl | H | Ph | 46 (35) | 3:1 | |
| 16 | H | 2-thienyl | H | Ph | 52 (39) | 3:1 | |
| 17 | H | COOEt | Bn | Ph | 88 (77) | 7:1 | |
| 18 | H | COOEt | Boc | Ph | 82 (71) | 6:1 | |
| 19 | H | COOEt | H | 3-Me-C6H4 | 70 (58) | 5:1 | |
| 20 | H | COOEt | H | 4-CF3-C6H4 | 67 (56) | 5:1 |
a See entry 15 and footnote “a” in Table 1. b Total yield of the mixed two isomers; the yield of the isolated major isomer 3 was shown in parentheses. c Based on crude 1H-NMR analysis of the mixed two isomers.
Figure 2X-ray structure of 3a.
Scheme 3Synthesis of pharmacologically important spiro-pyrrolidines.